Skip to main content

Animations

MJFF Publications

1911 - 1920 of 8399 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • OPEN
    Title: Transition Services for Children and Young Adults with Movement Disorders: A Survey by the MDS Task Force on Pediatrics
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13549
    Citation Count: 2
  • OPEN
    Title: Unveiling the B cell receptor structure
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.add8065
    Citation Count: 10
  • OPEN
    Title: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utility
    Journal Name: Seizure: European Journal of Epilepsy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003
    Citation Count: 6
  • RESTRICTED
    Title: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach
    Journal Name: Neuropeptides
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283
    Best OA location URL:
    Citation Count: 9
  • OPEN
    Title: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002
    Citation Count: 10
  • OPEN
    Title: Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-022-00554-8
    Citation Count: 25
  • RESTRICTED
    Title: Endosomal-Lysosomal and Autophagy Pathway in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    Journal Name: Journal of Alzheimer's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3233/jad-220360
    Best OA location URL:
    Citation Count: 8
  • RESTRICTED
    Title: Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200699
    Citation Count: 26
  • RESTRICTED
    Title: Neuroprotective Trials in REM Sleep Behavior Disorder
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200235
    Citation Count: 21
  • RESTRICTED
    Title: Outcome Assessment in Parkinson Disease Prevention Trials
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200236
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.